Patents by Inventor Rajendra Nandlal Nagori

Rajendra Nandlal Nagori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10485812
    Abstract: The lyophilized solid pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: November 26, 2019
    Assignee: WOCKHARDT LIMITED
    Inventors: Bhaskar Chauhan, Rajendra Nandlal Nagori, Yatendra Kumar Gupta
  • Publication number: 20180064722
    Abstract: Pharmaceutical compositions comprising cefepime or a pharmaceutically acceptable salt thereof, tazobactam or a pharmaceutically acceptable salt thereof, and arginine or a pharmaceutically acceptable salt thereof; and their use in treatment, control or prevention of bacterial infection is disclosed.
    Type: Application
    Filed: March 31, 2017
    Publication date: March 8, 2018
    Applicant: WOCKHARDT LIMITED
    Inventors: Manohar Baburao NANDANWAR, Atul KANSAGARA, Rajendra Nandlal NAGORI, Muftedar Ahmed Iftekhar PATEL, Ravindra Dattatraya YEOLE, Bhaskar CHAUHAN, Keshav DEO, Mahesh Vithalbhai PATEL
  • Publication number: 20180064691
    Abstract: Pharmaceutical compositions comprising cefepime or a pharmaceutically acceptable salt thereof, tazobactam or a pharmaceutically acceptable salt thereof, and arginine or a pharmaceutically acceptable salt thereof; and their use in treatment, control or prevention of bacterial infection is disclosed.
    Type: Application
    Filed: March 31, 2017
    Publication date: March 8, 2018
    Applicant: WOCKHARDT LIMITED
    Inventors: Bhaskar CHAUHAN, Rajendra Nandlal NAGORI, Dharmvir Singh YADAV, Keshav DEO, Avadhesh Kumar SHARMA, Yatendra KUMAR
  • Publication number: 20180028549
    Abstract: The lyophilized solid pharmaceutical compositions comprising a compound of Formula (I) or a stereoisomer or a pharmaceutically acceptable derivative thereof are disclosed.
    Type: Application
    Filed: January 11, 2017
    Publication date: February 1, 2018
    Applicant: WOCKHARDT LIMITED
    Inventors: Bhaskar CHAUHAN, Rajendra Nandlal NAGORI, Yatendra Kumar GUPTA
  • Publication number: 20150246009
    Abstract: The present invention refers to a stabilized injectable pharmaceutical composition of epinephrine or salts thereof comprising sodium metabisulfite, wherein the ratio of the amount of epinephrine or salt thereof to sodium metabisulfite in the composition ranges from about 1:0.005 to about 1:1.5 by weight. It has been observed that stable injectable epinephrine compositions with excellent storage stability and substantially free of overages can be prepared using sodium metabisulfite in said ratios. Particularly, it was found that using sodium metabisulfite in said ratios controls levels of adrenaline sulfonate impurity in said pharmaceutical compositions.
    Type: Application
    Filed: May 3, 2013
    Publication date: September 3, 2015
    Applicant: WOCKHARDT LIMITED
    Inventors: Amit Gupta, Rajendra Nandlal Nagori, Arvind Yekanathsa Merwade, Keshav Deo, Girish Kumar Jain